Acquisition of Innovative Diagnostics Private Limited and Quest Laboratories Pte Ltd by Pathology Asia Holdings Pte Ltd

Parties Involved

• Pathology Asia Holdings Pte. Ltd.

• Innovative Diagnostics Private Limited

• Quest Laboratories Pte. Ltd.

Focus of Commitments/ Remedies

The commitments work together to address the competition concerns identified by:

• Helping competing laboratories offer a wider range of IVD tests and be better able to compete for customers, and gauge demand to consider in-house expansion;

• Lowering contractual barriers for customers to switch to other suppliers, and increase competing laboratories’ incentives to expand; and

• Mitigating the risk of a price increase or a degradation of quality by the merged entity during the commitment period, for customers who have limited alternatives to switch to at present.

Start Date of Commitments/ Remedies

18 October 2019

End Date of Commitments/ Remedies

17 October 2023